From November 3, 2023 to December 7, 2023, the company has repurchased 1,550,900 shares, representing 0.38% for CNY 29.99 million. With this, the company has completed the repurchase of 1,550,900 shares, representing 0.38% for CNY 29.99 million under the buyback announced on November 4, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.43 CNY | +0.78% | +5.11% | -18.27% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.27% | 873M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 603439 Stock
- News GuiZhou SanLi Pharmaceutical Co.,Ltd
- Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 4, 2023.